Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AFF1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | SIX2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | KMT2B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | GRPEL2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
mRNA | DCAF16 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | ZNF506 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | PHOSPHO2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | ZNF439 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | RETNLB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | RPRD1A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |